|
|||||||||||||||
| EDITORIAL BOARD MEMBERS | |||||||||||||||
|
|
|
|
|||||||||||||
|
Mark A. Munger,
PhD
Professor, Pharmacotherapy |
|
||||||||||||||
|
Biosketch |
|||||||||||||||
|
Dr. Munger graduated from Oregon State University with a B.S. in Pharmacy, received his Pharm.D. from the University of Illinois, and completed a Clinical Cardiovascular Pharmacology Research Fellowship from Case Western Reserve University School of Medicine in Cleveland, Ohio. He is currently a Professor of Pharmacotherapy and Adjunct Professor of Internal Medicine at the University of Utah. He is the Associate Dean of Academic Affairs for the College of Pharmacy at the University of Utah. Dr. Munger is a fellow in the American College of Clinical Pharmacy and in the American College of Cardiology. He is also a member of the AHA/ACC Guideline Writing Committee on Stable Ischemic Heart Disease. He has served as Chairman, University of Utah Institutional Review Board and Chairman, Board of Pharmacy, of the State of Utah. He currently serves as the Chairman, Utah State Department of Health Digital Health Commission.
His current research interests are furthering the understanding of nanotechnology toxicology in the human model. He is the author of 175 manuscripts and abstracts in human cardiovascular physiology and pharmacology, and in professional pharmacy matters.
|
|||||||||||||||
|
URL: |
|||||||||||||||
|
|
|||||||||||||||
|
|
|||||||||||||||
|
|
|||||||||||||||
